FUNCTIONAL RESULTS AND LONG-TERM OUTCOME AFTER BILATERAL LUNG TRANSPLANTATION FOR PULMONARY-HYPERTENSION

Citation
T. Birsan et al., FUNCTIONAL RESULTS AND LONG-TERM OUTCOME AFTER BILATERAL LUNG TRANSPLANTATION FOR PULMONARY-HYPERTENSION, Wiener Klinische Wochenschrift, 110(2), 1998, pp. 45-52
Citations number
24
Categorie Soggetti
Medicine, General & Internal
ISSN journal
00435325
Volume
110
Issue
2
Year of publication
1998
Pages
45 - 52
Database
ISI
SICI code
0043-5325(1998)110:2<45:FRALOA>2.0.ZU;2-4
Abstract
Pulmonary hypertension (PH) signifies elevated blood pressure in the p ulmonary circulation either due to clearly defined causes (cardiac, pu lmonary-parenchymatous, systemic) or of idiopathic origin (primary PH, PPH). While conservative treatment is beneficial only for a small num ber of patients, lung transplantation represents a curative measure. T he optimal form of transplantation [i. e. single lung (SLTX), bilatera l lung (BLTX) or combined heart-lung transplantation (HLTX)] is still under discussion. This study is a retrospective analysis of 16 patient s with different forms of PH who underwent BLTX from 1992 to 1996 in V ienna. Four patients had Eisenmenger's disease due to atrial septum de fect, 3 had chronic thromboembolic PH and 9 had PPH. BLTX with cardiop ulmonary bypass was the standard procedure in all patients. Acute retr ansplantation had to be performed in 3 patients. Mean pulmonary arteri al pressure was reduced from 63 +/- 11 mmHg preoperatively to 23 +/- 5 mmHg on the second day postoperatively (p < 0.0001), while the cardia c index concomitantly improved from 2.1 +/- 0.5 to 3.9 +/- 1.2 l/min/m (2) (p < 0.05). Echocardiography proved normalisation of right ventric ular wall thickness and end diastolic diameter within 12 months, while tricuspid insufficiency, present in all patients before transplantati on, resolved completely. Perioperatively 4 patients (25%) died due to septic complications (n = 3) or therapy refractory rejection (n = 1). Follow-up of the remaining patients ranged from 6 to 51 months (mean 3 3 +/- 17). One patient died at 8 months due to fungal sepsis. Eleven p atients (68%) are currently alive. Only 2 of them show functional sign s of chronic allograft rejection (bronchiolitis obliterans syndrome). All patients are at present in NYHA functional class I or II. In concl usion, BLTX results in complete recovery of right ventricular function and morphology and offers good functional long-term results. Because SLTX correlates with a high incidence of reperfusion edema, and HLTX i s seriously limited by the scarcity of donor organs, BLTX should be th e method of choice for treating end stage PH.